# Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis

> **NCT04973670** · PHASE3 · UNKNOWN · sponsor: **Southeast University, China** · enrollment: 238 (estimated)

## Conditions studied

- ARDS

## Interventions

- **DRUG:** Sivelestat sodium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04973670
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-11
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-10-30
- **Target enrollment:** 238 (ESTIMATED)
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04973670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04973670, "Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04973670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*